Sometimes, even the most hyped drugs fail. This was the case for Pfizer’s drug torcetrapib, which was meant to help with cholesterol levels. Unfortunately, in the final phase of drug trials, it was discovered this medicine that the company had poured billions of dollars in to in fact did not work. The results were difficult for the scientists and researchers who had spent years investing time into this drug, and were so hopeful for it success. It took time, but they have learned from the failure, and are now moving on to work on new medications.
On Experiencing The Failure Of A Billion Dollar Clinical Program
Download our eBook “Moving To The US”
Disclaimer:
This document is intended as an information source only. The comments and references to legislation and other sources in this publication do not constitute legal advice and should not be relied upon as such. You should seek advice from a professional adviser regarding the application of any of the comments in this document to your fact scenario. Information in this publication does not take into account any person’s personal objectives, needs or financial situations. Accordingly, you should consider the appropriateness of any information, having regard to your own objectives, financial situation and needs and seek professional advice before acting on it. CST Tax Advisors exclude all liability (including liability for negligence) in relation to your reliance in this publication.